A new coronavirus vaccination campaign is slated for April 16 to 20, 2022 in Cameroon. During the exercise, 600,000 persons are expected to be vaccinated.
The campaign which will be carried out by the Enlarged Programme of Vaccination (EPV) will see the deployment of 1,800 teams in 1,814 health zones within the 20 regions of the country, during which 600,000 doses of the Johnson & Johnson, Pfizer and SINOPHARM vaccines would be administered on an equal number of volunteer recipients.
This fourth vaccination campaign aims at reinforcing the immune systems of persons at a time when Cameroon is seeing a drastic drop in COVID-19 cases.
It is also intended to avoid a resurgence of cases of the coronavirus since the evolution of the virus presents particularities which the medical personnel find difficult to master.
“In organising this campaign, we are reassured by the fact that the pandemic has been contained. On the one hand, the perception of risks of the pandemic is very weak and the adhesion to vaccination would be very reduced,” said Dr Tchokfe Shalom, Permanent Secretary of the Enlarged Programme of Vaccination.
“On the other hand, we know that at this moment, the evolution of the pandemic includes uncertainties which we do not master. It is thus important that at the time we are in a calm period, persons should again reinforce their immunity.”
The campaign is estimated to cost 500 million FCFA (about 1 million US dollars), and each administered dose is estimated to cost 2 to 4 US dollars.
Support Our Journalism
There are millions of ordinary people affected by conflict in Africa whose stories are missing in the mainstream media. HumAngle is determined to tell those challenging and under-reported stories, hoping that the people impacted by these conflicts will find the safety and security they deserve.
To ensure that we continue to provide public service coverage, we have a small favour to ask you. We want you to be part of our journalistic endeavour by contributing a token to us.
Your donation will further promote a robust, free, and independent media.Donate Here